Literature DB >> 20859222

Cytomegalovirus as a trigger for systemic lupus erythematosus.

Arnaldo E Pérez-Mercado1, Salvador Vilá-Pérez.   

Abstract

Cytomegalovirus (CMV) infections have been associated with exacerbations of systemic lupus erythematosus (SLE). Their role in triggering this disease, however, remains a subject of debate. We present a 43-year-old man with no history of systemic illness who developed persistent signs and symptoms of a CMV-associated mononucleosis-like syndrome while fulfilling diagnostic criteria for previously undiagnosed SLE. The patient was admitted with persistent fever for 3 weeks, cervical lymphadenopathy, elevated liver function tests, and leukopenia. Further laboratory studies revealed positive antinuclear antibody, anti-dsDNA, anti-Sm/RNP, rheumatoid factor, and anticardiolipin antibodies along with decreased complement levels and proteinuria of 876 mg/dL. CMV immunoglobulin M was positive in the absence of CMV immunoglobulin G, supporting acute CMV infection. Symptoms improved with intravenous administration of methylprednisolone and ganciclovir therapy. Mechanisms by which CMV may trigger autoimmunity have been proposed, and this case could support CMV infection as a potential trigger for SLE in susceptible individuals.

Entities:  

Mesh:

Year:  2010        PMID: 20859222     DOI: 10.1097/RHU.0b013e3181f4cf52

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  19 in total

1.  [Consistency analysis and clinical guiding significance of cytomegalovirus nucleic acid and antibody detections in patients with different clinical characteristics].

Authors:  J H Dai; X P Sun; J Zhang; L J Shi
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-18

2.  Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.

Authors:  Evelyn V Rozenblyum; Upton D Allen; Earl D Silverman; Deborah M Levy
Journal:  Int J Clin Rheumtol       Date:  2013-02

3.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

4.  Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case-control study.

Authors:  Bradley J Gardiner; Erica M Haas; Rosemary C Bailey; Jennifer K Chow; David R Snydman
Journal:  Rheumatol Int       Date:  2019-05-10       Impact factor: 3.580

5.  Analysis of Erythrocyte C4d to Complement Receptor 1 Ratio: Use in Distinguishing between Infection and Flare-Up in Febrile Patients with Systemic Lupus Erythematosus.

Authors:  Chen-Hung Chen; Shun-Ban Tai; Hsiang-Cheng Chen; Deng-Ho Yang; Ming-Yieh Peng; Yuh-Feng Lin
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

6.  STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells.

Authors:  Guanjun Dong; Ming You; Liang Ding; Hongye Fan; Fei Liu; Deshan Ren; Yayi Hou
Journal:  Mol Cells       Date:  2015-05-07       Impact factor: 5.034

7.  Cytomegalovirus as a potential trigger for systemic lupus erythematosus: a case report.

Authors:  Susumu Yamazaki; Amane Endo; Takashi Iso; Shinpei Abe; You Aoyagi; Mitsuyoshi Suzuki; Toru Fujii; Hidenori Haruna; Yoshikazu Ohtsuka; Toshiaki Shimizu
Journal:  BMC Res Notes       Date:  2015-09-28

8.  The expression of renal Epstein-Barr virus markers in patients with lupus nephritis.

Authors:  Xiao-Xia Yu; Cui-Wei Yao; Jing-Li Tao; Chen Yang; Mian-Na Luo; Shang-Mei Li; Hua-Feng Liu
Journal:  Exp Ther Med       Date:  2014-02-24       Impact factor: 2.447

Review 9.  Human cytomegalovirus and autoimmune disease.

Authors:  Anne Halenius; Hartmut Hengel
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

10.  Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease.

Authors:  Kine Edvardsen; Alexander Hellesen; Eystein S Husebye; Eirik Bratland
Journal:  J Transl Med       Date:  2016-03-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.